VYNE THERAPEUTICS INC's ticker is VYNE and the CUSIP is 92941V209. A total of 42 filers reported holding VYNE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $73 | -99.8% | 488,012 | +145.6% | 0.00% | – |
Q3 2022 | $44,000 | -31.2% | 198,714 | +20.9% | 0.00% | – |
Q2 2022 | $64,000 | -72.2% | 164,415 | -53.6% | 0.00% | – |
Q1 2022 | $230,000 | -47.7% | 354,001 | -18.0% | 0.00% | – |
Q4 2021 | $440,000 | -26.8% | 431,485 | -0.2% | 0.00% | – |
Q3 2021 | $601,000 | -74.8% | 432,424 | -36.3% | 0.00% | -100.0% |
Q2 2021 | $2,384,000 | +1239.3% | 679,211 | +2513.0% | 0.00% | – |
Q1 2021 | $178,000 | – | 25,994 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 400,000 | $2,738,000 | 6.10% |
DSC Advisors, L.P. | 1,038,145 | $7,106,000 | 4.40% |
CM Management, LLC | 143,750 | $984,000 | 0.73% |
Perceptive Advisors | 6,773,954 | $46,368,000 | 0.59% |
DELTEC ASSET MANAGEMENT LLC | 441,491 | $3,022,000 | 0.45% |
Perennial Investment Advisors, LLC | 35,000 | $240,000 | 0.10% |
Tekla Capital Management LLC | 135,395 | $927,000 | 0.03% |
NEXPOINT ASSET MANAGEMENT, L.P. | 10,051 | $69,000 | 0.02% |
AXA S.A. | 882,124 | $6,038,000 | 0.02% |
STALEY CAPITAL ADVISERS INC | 25,000 | $171,000 | 0.01% |